Veracyte Historical Income Statement

VCYT Stock

USD 42.89 0.05 0.12%

Historical analysis of Veracyte income statement accounts such as Depreciation And Amortization of 28.5 M, Interest Expense of 14.2 K, Selling General Administrative of 165.5 M or Selling And Marketing Expenses of 40.9 M can show how well Veracyte performed in making a profits. Evaluating Veracyte income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Veracyte's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Veracyte latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Veracyte is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

About Veracyte Income Statement Analysis

Veracyte Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Veracyte shareholders. The income statement also shows Veracyte investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Veracyte Income Statement Chart

At this time, Veracyte's Total Operating Expenses is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 9.6 M in 2024, despite the fact that EBIT is likely to grow to (72.8 M).

Selling General Administrative Selling And Marketing Expenses Total Revenue Other Operating Expenses Operating Income

Total Revenue

Total revenue comprises all receipts Veracyte generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Veracyte. It is also known as Veracyte overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Veracyte operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Veracyte is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Veracyte's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Veracyte current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.At this time, Veracyte's Total Operating Expenses is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 9.6 M in 2024, despite the fact that EBIT is likely to grow to (72.8 M).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	227.0M	236.0M	333.9M	350.6M
Cost Of Revenue	74.4M	101.6M	112.9M	118.5M

Total Operating Expenses Cost Of Revenue

Veracyte income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Income From Continuing Ops	Non Operating Income Net Other	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		-0.27	0.92	0.67	0.98	0.97	0.97	-0.84	-0.8	0.94	-0.47	0.98	0.96	-0.79	0.82	-0.81	-0.46	-0.69	0.84	0.55	0.9	0.93
Interest Expense	-0.27		-0.24	0.01	-0.2	-0.21	-0.21	0.23	0.22	-0.21	0.14	-0.19	-0.22	0.16	-0.23	0.16	0.65	0.18	-0.04	0.39	-0.45	-0.31
Selling General Administrative	0.92	-0.24		0.43	0.96	0.96	0.98	-0.95	-0.91	0.98	-0.7	0.95	0.99	-0.91	0.87	-0.92	-0.51	-0.75	0.81	0.69	0.93	0.83
Selling And Marketing Expenses	0.67	0.01	0.43		0.61	0.59	0.58	-0.42	-0.42	0.47	-0.13	0.64	0.56	-0.42	0.25	-0.43	-0.17	-0.45	0.6	0.08	0.39	0.62
Total Revenue	0.98	-0.2	0.96	0.61		1.0	1.0	-0.86	-0.82	0.99	-0.52	1.0	0.99	-0.82	0.88	-0.84	-0.39	-0.65	0.91	0.67	0.94	0.88
Gross Profit	0.97	-0.21	0.96	0.59	1.0		1.0	-0.86	-0.82	0.99	-0.52	1.0	0.99	-0.81	0.89	-0.83	-0.39	-0.65	0.91	0.67	0.94	0.87
Other Operating Expenses	0.97	-0.21	0.98	0.58	1.0	1.0		-0.9	-0.87	0.99	-0.59	0.99	1.0	-0.86	0.87	-0.88	-0.44	-0.71	0.88	0.66	0.93	0.88
Operating Income	-0.84	0.23	-0.95	-0.42	-0.86	-0.86	-0.9		0.99	-0.88	0.87	-0.86	-0.91	0.99	-0.69	0.99	0.65	0.91	-0.64	-0.56	-0.81	-0.8
Ebit	-0.8	0.22	-0.91	-0.42	-0.82	-0.82	-0.87	0.99		-0.83	0.9	-0.82	-0.88	1.0	-0.62	1.0	0.69	0.93	-0.59	-0.5	-0.76	-0.77
Research Development	0.94	-0.21	0.98	0.47	0.99	0.99	0.99	-0.88	-0.83		-0.56	0.98	0.99	-0.83	0.92	-0.85	-0.4	-0.65	0.88	0.73	0.95	0.85
Ebitda	-0.47	0.14	-0.7	-0.13	-0.52	-0.52	-0.59	0.87	0.9	-0.56		-0.52	-0.61	0.91	-0.34	0.89	0.69	0.88	-0.27	-0.35	-0.49	-0.46
Cost Of Revenue	0.98	-0.19	0.95	0.64	1.0	1.0	0.99	-0.86	-0.82	0.98	-0.52		0.99	-0.82	0.86	-0.84	-0.4	-0.67	0.9	0.66	0.92	0.89
Total Operating Expenses	0.96	-0.22	0.99	0.56	0.99	0.99	1.0	-0.91	-0.88	0.99	-0.61	0.99		-0.87	0.87	-0.89	-0.46	-0.72	0.87	0.67	0.94	0.87
Income Before Tax	-0.79	0.16	-0.91	-0.42	-0.82	-0.81	-0.86	0.99	1.0	-0.83	0.91	-0.82	-0.87		-0.61	1.0	0.66	0.94	-0.58	-0.53	-0.74	-0.76
Total Other Income Expense Net	0.82	-0.23	0.87	0.25	0.88	0.89	0.87	-0.69	-0.62	0.92	-0.34	0.86	0.87	-0.61		-0.63	-0.18	-0.38	0.87	0.76	0.92	0.7
Net Income	-0.81	0.16	-0.92	-0.43	-0.84	-0.83	-0.88	0.99	1.0	-0.85	0.89	-0.84	-0.89	1.0	-0.63		0.64	0.92	-0.62	-0.55	-0.76	-0.77
Income Tax Expense	-0.46	0.65	-0.51	-0.17	-0.39	-0.39	-0.44	0.65	0.69	-0.4	0.69	-0.4	-0.46	0.66	-0.18	0.64		0.72	-0.06	0.12	-0.46	-0.52
Net Income From Continuing Ops	-0.69	0.18	-0.75	-0.45	-0.65	-0.65	-0.71	0.91	0.93	-0.65	0.88	-0.67	-0.72	0.94	-0.38	0.92	0.72		-0.35	-0.3	-0.55	-0.69
Non Operating Income Net Other	0.84	-0.04	0.81	0.6	0.91	0.91	0.88	-0.64	-0.59	0.88	-0.27	0.9	0.87	-0.58	0.87	-0.62	-0.06	-0.35		0.69	0.84	0.71
Interest Income	0.55	0.39	0.69	0.08	0.67	0.67	0.66	-0.56	-0.5	0.73	-0.35	0.66	0.67	-0.53	0.76	-0.55	0.12	-0.3	0.69		0.58	0.43
Net Interest Income	0.9	-0.45	0.93	0.39	0.94	0.94	0.93	-0.81	-0.76	0.95	-0.49	0.92	0.94	-0.74	0.92	-0.76	-0.46	-0.55	0.84	0.58		0.8
Reconciled Depreciation	0.93	-0.31	0.83	0.62	0.88	0.87	0.88	-0.8	-0.77	0.85	-0.46	0.89	0.87	-0.76	0.7	-0.77	-0.52	-0.69	0.71	0.43	0.8

Click cells to compare fundamentals

Veracyte Account Relationship Matchups

Veracyte income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	7.3M	8.9M	21.2M	29.2M	27.2M	28.5M
Interest Expense	677K	229K	241K	198K	15K	14.3K
Selling General Administrative	29.0M	36.7M	101.4M	76.5M	157.6M	165.5M
Selling And Marketing Expenses	53.7M	52.4M	79.8M	97.6M	26.6M	40.9M
Total Revenue	120.4M	117.5M	219.5M	296.5M	361.1M	379.1M
Gross Profit	83.8M	76.0M	145.1M	195.0M	248.1M	260.6M
Other Operating Expenses	135.5M	152.9M	301.4M	337.6M	446.8M	469.2M
Operating Income	(15.1M)	(35.4M)	(81.9M)	(41.1M)	(85.8M)	(81.5M)
Ebit	(15.1M)	(34.7M)	(81.4M)	(36.2M)	(76.6M)	(72.8M)
Research Development	14.9M	17.2M	29.8M	40.6M	57.3M	60.2M
Ebitda	(7.8M)	(25.8M)	(60.2M)	(7.0M)	(49.4M)	(46.9M)
Cost Of Revenue	36.5M	41.5M	74.4M	101.6M	112.9M	118.5M
Total Operating Expenses	99.0M	111.4M	227.0M	236.0M	333.9M	350.6M
Income Before Tax	(12.6M)	(34.9M)	(81.6M)	(36.4M)	(76.6M)	(72.8M)
Total Other Income Expense Net	2.5M	480K	254K	4.7M	9.2M	9.6M
Net Income	(16.5M)	(35.8M)	(75.6M)	(36.6M)	(74.4M)	(70.7M)
Income Tax Expense	3.9M	938K	(6.1M)	133K	(2.2M)	(2.1M)
Net Income From Continuing Ops	(12.6M)	(34.9M)	(75.6M)	(36.6M)	(50.0M)	(52.5M)
Non Operating Income Net Other	3.2M	709K	254K	4.7M	5.4M	5.6M
Net Income Applicable To Common Shares	(12.6M)	(34.9M)	(75.6M)	(36.6M)	(32.9M)	(34.5M)
Interest Income	677K	594K	135K	2.0M	5.7M	5.9M
Net Interest Income	(677K)	(229K)	(106K)	1.8M	5.6M	5.9M
Reconciled Depreciation	4.1M	7.9M	19.6M	25.9M	27.4M	14.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Veracyte Historical Income Statement

About Veracyte Income Statement Analysis

Veracyte Income Statement Chart

Total Revenue

Other Operating Expenses

Operating Income

Veracyte income statement Correlations

Veracyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Veracyte income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Veracyte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit
Cost Of Revenue	+ 1.0	Gross Profit
Total Operating Expenses	+ 1.0	Other Operating Expenses

Operating Income	- 0.95	Selling General Administrative
Net Income	- 0.92	Selling General Administrative
Total Operating Expenses	- 0.91	Operating Income
Income Before Tax	- 0.91	Selling General Administrative
Ebit	- 0.91	Selling General Administrative
Operating Income	- 0.9	Other Operating Expenses